A Prospective Randomised Trial of Early LV Venting Using Impella CP for Recovery in patients with cardiogenic managed with VA ECMO (REVERSE)

  • STATUS
    Recruiting
  • participants needed
    96
Send
Updated on 19 February 2024

Summary

Veno-arterial (VA) extra-corporeal membrane oxygenation (ECMO) is indicated as a haemodynamic rescue strategy in decompensated acute or chronic heart failure presenting as cardiogenic shock. VA ECMO has a number of effects on the circulation including (i) perfusing end-organs, (ii) ventricular unloading, and (iii) improved coronary perfusion. It is a bridge to further therapies, to withdrawal of advanced therapies or to cardiac recovery. The VA ECMO platform in combination with a left ventricle (LV) vent allows for optimization of mechanical load of the LV, and thus for LV recovery. Over the last two decades, a large body of evidence has amassed to provide compelling evidence that mechanical load optimisation is critical to recovering the LV. The Impella device provides a percutaneous means of direct ventricular unloading with a remarkable safety profile. There is non-randomised data that suggests the addition of Impella CP in combination with VA ECMO improves survival and cardiac recovery in patients with cardiogenic shock. This research study will provide valuable data on changes at multiple levels with full and iteratively reduced mechanical circulatory support. It will provide the first randomised data to address this question directly.

Details
Condition Cardiogenic Shock
Age 99years or below
Clinical Study IdentifierN/A
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.